Lexagene Holdings (Lexagene Holdings) EV-to-EBITDA : -1.61 (As of Jun. 04, 2024)

Lexagene Holdings EV-to-EBITDA Chart

Lexagene Holdings Annual Data
	Trend	Mar13	Mar14	Mar15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22
EV-to-EBITDA		Get a 7-Day Free Trial					-14.34	-3.99	-8.72	-10.39	-2.74

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EV-to-EBITDA	Get a 7-Day Free Trial															-4.44	-2.74	-2.16	-2.33	-3.11

Competitive Comparison of Lexagene Holdings's EV-to-EBITDA

For the Medical Devices subindustry, Lexagene Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's EV-to-EBITDA falls into.

Lexagene Holdings EV-to-EBITDA Calculation

Lexagene Holdings's EV-to-EBITDA for today is calculated as:

Lexagene Holdings's current Enterprise Value is $12.23 Mil.
Lexagene Holdings's EBITDA for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexagene Holdings  (OTCPK:LXXGQ) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lexagene Holdings's PE Ratio for today is calculated as:

Lexagene Holdings's share price for today is $0.0806.
Lexagene Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.070.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Lexagene Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description